What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Retina
The scientist’s investigation covers issues in Ophthalmology, Macular degeneration, Retina, Retinal and Surgery.
His work deals with themes such as Retinopathy and Maculopathy, which intersect with Ophthalmology.
His Macular degeneration research incorporates elements of Retinal pigment epithelium, Choroid, Ranibizumab and Atrophy.
Sebastian Wolf combines subjects such as Endocrinology, Optical coherence tomography, Blood flow, Anatomy and Hemodynamics with his study of Retina.
His Retinal research integrates issues from Autofluorescence, Glutamate receptor, Optometry, Pathology and Internal medicine.
His Surgery research is multidisciplinary, incorporating elements of Topical medication, Panretinal photocoagulation, Blood pressure and Intravitreal bevacizumab.
His most cited work include:
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study (552 citations)
- Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. (338 citations)
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials (255 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Ophthalmology, Retinal, Macular degeneration, Surgery and Visual acuity.
His Ophthalmology research incorporates themes from Retinopathy and Ranibizumab.
His research combines Eye disease and Retinopathy.
His work focuses on many connections between Retinal and other disciplines, such as Autofluorescence, that overlap with his field of interest in Pathology.
His research in Macular degeneration intersects with topics in Optometry, Regimen, Aflibercept and Age related.
His Fluorescein angiography research is multidisciplinary, relying on both Diabetic retinopathy, Maculopathy, Ophthalmoscopy, Angiography and Microcirculation.
He most often published in these fields:
- Ophthalmology (43.10%)
- Retinal (20.71%)
- Macular degeneration (17.48%)
What were the highlights of his more recent work (between 2015-2021)?
- Ophthalmology (43.10%)
- Retinal (20.71%)
- Macular degeneration (17.48%)
In recent papers he was focusing on the following fields of study:
Sebastian Wolf spends much of his time researching Ophthalmology, Retinal, Macular degeneration, Optical coherence tomography and Visual acuity.
His study in the field of Choroidal neovascularization also crosses realms of In patient.
The Retinal study combines topics in areas such as Autofluorescence, Retina and Artificial intelligence.
His studies deal with areas such as Retrospective cohort study, Treat and extend regimen, Immunology and Age related as well as Macular degeneration.
His Optical coherence tomography research focuses on Biomedical engineering and how it connects with Wide field.
His Visual acuity study combines topics from a wide range of disciplines, such as Pro re nata, Adverse effect and Randomized controlled trial.
Between 2015 and 2021, his most popular works were:
- Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. (181 citations)
- OCT-angiography: A qualitative and quantitative comparison of 4 OCT-A devices. (102 citations)
- Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. (90 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Retina
Sebastian Wolf focuses on Ophthalmology, Retinal, Visual acuity, Macular degeneration and Optical coherence tomography.
His research integrates issues of Diabetic retinopathy, Ranibizumab and Retrospective cohort study in his study of Ophthalmology.
Sebastian Wolf interconnects Retina, Autofluorescence and Artificial intelligence in the investigation of issues within Retinal.
Treat and extend regimen is closely connected to Regimen in his research, which is encompassed under the umbrella topic of Visual acuity.
His study looks at the relationship between Macular degeneration and fields such as Clinical trial, as well as how they intersect with chemical problems.
The study incorporates disciplines such as Nuclear medicine, Perimeter and Medical imaging in addition to Optical coherence tomography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
